Medisyn Technologies Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Medisyn Technologies General Information

Description

Developer of bioactive drug compounds designed to focus on discovering new treatments for cancer. The company's bioactive drug compounds are use for the treatment of infectious diseases, cancer and Alzheimer's disease, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6109 Blue Circle Drive
  • Suite 1000
  • Minnetonka, MN 55343
  • United States
+1 (952)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6109 Blue Circle Drive
  • Suite 1000
  • Minnetonka, MN 55343
  • United States
+1 (952)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medisyn Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 27-Apr-2016 Completed Out of Business
6. Secondary Transaction - Private 03-May-2013 Completed Generating Revenue
5. Early Stage VC 06-Oct-2009 Completed Generating Revenue
4. Grant 25-Jan-2008 Completed Generating Revenue
3. Later Stage VC (Series B) 25-May-2007 Completed Generating Revenue
2. Later Stage VC 01-May-2006 $1.6M Completed Generating Revenue
1. Early Stage VC 27-Nov-2002 $1.6M $1.6M Completed Startup
To view Medisyn Technologies’s complete valuation and funding history, request access »

Medisyn Technologies Patents

Medisyn Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015142670-A1 Anti-diabetic compounds, pharmaceutical compositions containing them, and method to treat diabetes Inactive 15-Mar-2014
AU-2010232923-A1 Compositions for treatment of alzheimer's disease Inactive 03-Apr-2009
CA-2759187-A1 Compositions for treatment of alzheimer's disease Inactive 03-Apr-2009
EP-2413696-A1 Compositions for treatment of alzheimer's disease Inactive 03-Apr-2009
EP-2413696-A4 Compositions for treatment of alzheimer's disease Inactive 03-Apr-2009 A61K31/513
To view Medisyn Technologies’s complete patent history, request access »

Medisyn Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medisyn Technologies FAQs

  • When was Medisyn Technologies founded?

    Medisyn Technologies was founded in 1999.

  • Where is Medisyn Technologies headquartered?

    Medisyn Technologies is headquartered in Minnetonka, MN.

  • What is the size of Medisyn Technologies?

    Medisyn Technologies has 4 total employees.

  • What industry is Medisyn Technologies in?

    Medisyn Technologies’s primary industry is Drug Discovery.

  • Is Medisyn Technologies a private or public company?

    Medisyn Technologies is a Private company.

  • What is Medisyn Technologies’s current revenue?

    The current revenue for Medisyn Technologies is .

  • How much funding has Medisyn Technologies raised over time?

    Medisyn Technologies has raised $6.02M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process